Karen Autio, MD

Karen Autio, MD, Memorial Sloan Kettering Hospital

Articles by Karen Autio, MD

Brian Rini, MD, FASCOProstate Cancer | October 29, 2024
The panelists examine the existing data for T cell engagers in CRPC and how the data might affect clinical practice.
View More
Brian Rini, MD, FASCOProstate Cancer | October 29, 2024
The panelists discuss T cell engagers, including an introduction and discussion of cytokine release syndrome.
Brian Rini, MD, FASCORLT | October 29, 2024
The panel discusses the emerging field of PSMA-targeted alpha radioligand therapy, with a focus on HK2.
Brian Rini, MD, FASCORLT | October 29, 2024
The panel discusses the results of PEACE-3, which evaluated enzalutamide with or without radium-223 for MCRPC.
Brian Rini, MD, FASCORLT | October 29, 2024
The panel discusses two significant trials in metastatic hormone-sensitive prostate cancer.
Brian Rini, MD, FASCORLT | October 25, 2024
Part 2 of the Radioligands session from Uromigos Live 2024 features a discussion on the SPLASH results from ESMO 2024.
Brian Rini, MD, FASCORLT | October 24, 2024
The first part of five segments from the Uromigos Live 2024 session on radioligands.
Brian Rini, MD, FASCORLT | October 3, 2024
The Radioligands panel at Uromigos Live & Unplugged 2024 explored the role of RLT in prostate cancer treatment.
Brian Rini, MD, FASCOProstate Cancer | October 2, 2024
Watch the T Cell Directed Therapy in Prostate Cancer session from Uromigos Live 2024.